21 Sep 2025 | 5 Mins Read
Zydus gets positive USFDA update for Ahmedabad oncology plant
Flipitmoney
Zydus Lifesciences received an Establishment Inspection Report from the US FDA for its oncology injectable unit in Ahmedabad, India. The facility was classified as Voluntary Action Indicated, improving from an earlier Official Action Indicated status. The inspection resulted in no data integrity issues. This is an improvement in regulatory compliance, seen as a positive development for Zydus.